Skip to main content
Sleep Science logoLink to Sleep Science
. 2021 Jan-Mar;14(1):11–18. doi: 10.5935/1984-0063.20190154

Sleep quality among cardiac patients on follow up at Jimma Medical Center, southwestern Ethiopia

Yared Getahun 1, Wondu Reta Demissie 2,*, Hiwot Amare 1
PMCID: PMC8157786  PMID: 34104332

Abstract

Introduction

Chronic heart failure is associated with changes in sleep pattern and affects quality of sleep among patients with heart failure. Poor sleep has a negative impact on the patients’ quality of life, furthermore it compromises cognition and one’s self-care practice. Though, factors affecting sleep among heart failure patients have been investigated in developed world, there are limited studies in regards to it in developing countries like Ethiopia.

Objective

The aim of the study is to assess the level of sleep quality and associated factors among heart failure patients who are on follow up at Jimma Medical Center (JMC).

Material and Methods

Hospital based cross sectional study was employed among the total sample of 111 chronic heart failure patients admitted to medical ward and having follow up at cardiac center of JMC. The data was collected from April 1 - April 30, 2019 through face-to-face interview by using structured questionnaire. Pittsburg Sleep Quality Index (PSQI) was applied to assess sleep quality. PSQI score <5 refers to good sleep quality. Data was checked, cleaned for possible errors, entered into Epidata version 4.3.1 and finally exported to SPSS version 20 for further analysis. Appropriate statistical analyses (cross tabulation and logistic regression) were applied. A p value less than 0.05 was used to declare statistical significance.

Results

The mean age was 49±14 that ranges from 20-89 years by which majority of them 34 (30.6%) belongs to interval age of 35-44 years. The mean of PSQI score was 4.9±2.79 that ranges from 1-17 scores. Majority of the cardiac patients [69(62.2%)] were considered as having good sleep status (PSQI score <5) while the remaining 42 (37.8%) were considered as poor sleepers with PSQI score >5. Two variables (age of patients more than 65 years and presence of comorbidity) were identified as associated factors with poor sleep quality having P-value less than 0.05 and specific AOR with 95%CI of 4.087 (2.013-8.612) and 3.042 (1.074-8.619), respectively.

Conclusion

Poor sleep quality is common in heart failure patients. Age >65 years and comorbidities are predictors of poor sleep quality in these patients.

Keywords: Sleep Quality, PSQI, Cardiac Patients, JMC, Ethiopia, Associated Factors

INTRODUCTION

Heart failure (HF) is a growing problem worldwide, with almost 23 million people affected. It is estimated that by 2030 the prevalence will increase to 25% from current estimates1. The prevalence of HF rises exponentially with age and affects 4% to 8% of people older than 65 years2. The overall prevalence of HF is thought to be increasing and putting it as a major public health issue, with a prevalence of over 5.8 million in the USA, and over 23 million worldwide, and rising3,4.

Sleep is an important aspect of maintaining the body’s circadian rhythm5,6. Inadequate sleep contributes to heart disease, diabetes, depression, falls, accidents, impaired cognition, and a poor quality of life7. While normal aging changes interfere with the quality of sleep, other disease conditions and medications used by older adults also compromise sleep patterns8,9.

Disturbed sleep is among the most frequent health complaints that physicians encounter in their careers. More than one-half of adults in the United States experience at least intermittent sleep disturbance, and only 30% of adult Americans report consistently obtaining a sufficient amount of sleep10.

Chronic heart failure is an important cause of high levels of sleep disturbance and disorder11. Poor sleep is among the most frequently reported symptoms of patients with heart failure12. The proportion of poor sleepers among patients with HF is among the highest in chronic diseases13. Dyspnea and fatigue as common symptoms of this disease, significantly increase the chance of being a bad sleeper14.

The contributors of sleep disturbances among people with HF appear to be multi-factorial and complex. There is growing recognition that sleep-related breathing disorders, including Cheyne-Stokes respiration with central sleep apnea (CSR-CSA) and obstructive sleep apnea (OSA), are common in people with HF, with a range of 10% to 60%15. They have been shown consistently to cause sleep disruption due to repetitive arousals from sleep. It is evident that CSR-CSA is more likely to occur in patients with HF with left ventricular ejection fractions less than 45%, whereas OSA may be an independent risk factor to the development of HF and a consequence of HF16. Other factors that contribute to poor sleep in heart failure patients include demographic characteristics, pathophysiology of HF, comorbid health problems, symptoms of HF, medications and primary sleep disorders17.

Epidemiological studies are required and encouraged in regards/aspects of the common health problems of HF patients. However, unfortunately, there are limited studies that conducted on the sleep quality of HF patients in Ethiopian and at setting (the recent study reported that one third of hypertensive patients were poor sleepers)18. But the source population doesn’t represent the heart failure patients. Thus, it is worth to undertake studies related to sleep disturbance and associated factors among heart failure patients in Ethiopia and the present study aimed to determine sleep quality and its associated factors.

MATERIAL AND METHODS

The study was conducted in JMC from April 01-30/2019 among already diagnosed heart failure patients. Hospital based cross-sectional study was employed among randomly selected 111 samples of cardiac patients who admitted to medical ward and at follow up in cardiac center for treatment as the hospital guideline and protocol from an estimated 500 heart failure patients visiting the institution per year. The sample was enrolled from heart failure patients who had at least 6-month duration since visited the institution for treatment and/or follow up while heart failure patients with concomitant mental disorders and who take any medication were excluded from the study as they affect sleep quality.

JMC is one of the teaching referral hospitals of the country located in Jimma town, southwest of Ethiopia at about 350 Kilometers from the capital, Addis Ababa. JMC serves millions of patients dwelling in the catchments area of southwest part of the country. It has the cardiac unit that provides both inpatient and outpatient service for patients with CVDs.

Quality of sleep was assessed by using Pittsburg Sleep Quality Index (PSQI) tool, which has seven components: subjective sleep quality (Component 1), sleep latency (Component 2), sleep duration (Component 3), habitual sleep efficiency (Component 4), sleep disturbances (Component 5), use of sleep medicine (Component 6) and daytime dysfunction (Component 7)19. The result from all these seven components were calculated (added together to generate PSQI scores) and if the sum of the components yields PSQI score of less than 5, it is considered as respondents were good sleeper and PSQI score >5 refers to poor sleeper. PSQI was validated in the country and used as the best tool to assess sleep quality among different population of the country as well as the specific study setting (JMC)20.

The collected data was checked for completeness by principal investigator, and then data was entered into Epidata 4.3.1 version and finally exported to SPSS version 20 for further analysis. Descriptive statistics were performed by percentages, means, medians, standard deviations and ranges to describe finding. Cross tabulation and logistic regression were applied to determine the association between outcome variable (sleep status) and predictors. A p-value of 0.05 was declared as statistically significant. Ethical clearance was obtained from ethical review committee of Jimma University, Institute of Health Sciences. Both informed verbal and written consent was obtained. Participants’ confidentiality, equity of services and interests was ensured.

RESULTS

Socio-demographic status of cardiac patients

A total of 111 cardiac patients were enrolled with the mean age of 49±14 years that ranges from 20-89 years where majority of them 34 (30.6%) belongs to the age interval of 35-44 years, males 60 (54.1%), married 62(55.9%), private employee 29(26.1%), complete primary school 29(26.1%), Oromo 57 (51.4%), Muslims 60 (54.1%) and dwellers of urban 59 (53.2%), as detailed in Table 1.

Table 1.

Socio-demographic characteristics of cardiac patients at JMC, 2019.

Variables Categories Frequency Percentage (%)
Residence Urban 59 53.2
Rural 52 46.8
Sex Male 60 54.1
Female 51 45.9
Age  in years <34 17 15.3
35-44 34 30.6
45-54 22 19.8
55-64 18 16.2
>65 20 18.0
Educational status Can't read and write 22 19.8
Only read and write 8 7.2
Primary school 29 26.1
Secondary school 26 23.4
Higher education 26 23.4
Religious status Muslim 60 54.1
Orthodox 32 28.8
Protestant 16 14.4
Catholic 3 2.7
Ethnicity Oromo 57 51.4
Amhara 17 15.3
Tigre 9 8.1
SNNP 28 25.2
Occupation Farmer 21 18.9
House wife 27 25.2
Private 29 26.1
Public 16 14.4
Unemployed 7 6.3
Retired 10 9.0
Marital status Married 62 55.9
Widowed 12 10.8
Divorced 20 18.0
Single 17 15.3

Cardiac status of patients

Specific types of cardiac diseases were discriminated as congestive heart disease (CHD) 37 (33.3%), ischemic heart disease (IHD) 26 (23.4%), hypertension 20 (18.0%), rheumatic heart disease (RHD) 10 (9.0%) and others 18 (16.2%) like ischemic heart disease. Majority of the cardiac disease patients 55 (49.5%) had also other comorbidities like diabetes mellitus, thyroid disorders, stroke and renal problems. Majority of the cardiac disease patients 73 (65.8%) developed disease within five years and their heart status belong to stage two (39.6%) according to New York heart association (NYHA). The mean duration of illness was 5.1±4.9 years that range from 0.5-30 years as seen in supplement file in Table 5.

Table 5.

Cardiac status of patients at JMC, 2019

Variables Categories Frequency Percentage(%)
Presence of comorbidity Yes 55 49.5
No 56 50.5
Duration of disease ≤5years 73 65.8
>5years 38 34.2
Typeof disease CHD 37 33.3
RHD 10 9.0
IHD 26 23.4
HTN 20 18.0
Other 18 16.2
NYHA classification NYHAI 26 23.4
NYHAII 44 39.6
NYHAIII 19 17.1
NYHAIV 22 19.8

Substance use among cardiac patients

Current use of substance within the last three month was assessed among cardiac patients and majority of them were nonsmokers 98 (88.3%), non-drinkers 87 (78.4%), non-chewers 70 (73.1%), but majority of them 88 (79.3%) drink coffee/tea (supplement file in Table 6).

Table 6.

Substance use among cardiac patients at JMC, 2019

Variables Categories Frequency Percentage(%)
Smoking status Smoke 13 11.7
Not smoke 98 88.3
Alcoholic status Drinker 24 21.6
Not drinker 87 78.4
Chewings tatus Chewer 41 36.9
Not chewer 70 63.1
Coffee/tea drinking Drinking 88 79.3
Not drinking status 23 20.7

Sleep status of cardiac patients

Pittsburgh Sleep Quality Index (PSQI) was used to assess the quality and patterns of sleep among cardiac patients. Cardiac patients subjectively allocated their sleep status as very good 65 (58.6%), fairly good 31 (27.9%), fairly bad 10 (9.0%) and very bad 5 (4.5%) for component one and other components were summarized in Table 2. The mean of duration of time spent on the bed by cardiac patients was 8.7±1.5 hours that range from 2-14 hours but the mean duration of actual sleep time was 7.9±2.4 hours that range from 2-12 hours. The mean of duration of time taken to fall asleep was 29.72±19.3 minutes that range from 5-90 minutes as explained in detail in Table 2.

Table 2.

Sleep status among cardiac patients at JMC, 2019.

Variables Categories Frequency Percentage (%)
Component I (subjective perceived sleep quality) Very good (Score 0) 65 58.6
Fairly good (Score 1) 31 27.9
Fairly bad (Score 2) 10 9.0
Very bad (Score 3) 5 4.5
Component II (sleep latency)
Time taken to fall asleep plus 5A score.
Very good (Score 0) 9 8.1
Fairly good (Score 1) 64 57.7
Fairly bad (Score 2) 32 28.8
Very bad (Score 3) 6 5.4
Component III (Actual sleep duration in hours) >7 hours (Score 0) 75 67.6
6-7 hours (Score 1) 14 12.6
5-6 hours (Score 2) 18 16.2
<5 hours (Score 3) 4 3.6
Component IV
(Habitual sleep efficiency) (total # of hrs. asleep) x 100 (total # of hrs. in bed)
>85% (Very good) (Score 0) 74 66.7
75-84% (Fairly good) (Score 1) 22 19.8
65-74% (Fairly bad) (Score 2) 9 8.1
>65% (Very bad) (Score 3) 6 5.4
Component V (sleep disturbances)
Sum of Scores #5b to #5j (0=0; 1-9=1; 10-18=2; 19-27=3)
Very good (Score 0) 0 0
Fairly good (Score 1) 82 73.9
Fairly bad (Score 2) 29 26.1
Very bad (Score 3) 0 0
Component VI (use of sleep medicine) Not at all ( 0) 100 90.1
Less than once a week (1) 8 7.2
Once to twice a week (2) 3 2.7
Three or more times a week (3) 0 0
Component VII (Daytime dysfunction) Very good (Score 0) 60 54.1
Fairly good (Score 1) 41 36.9
Fairly bad (Score 2) 10 9.0
Very bad (Score 3) 0 0

Finally, the global PSQI score was computed for all patients by adding results of all components together. The mean of PSQI score was 4.9±2.79 that ranges from 1-17 scores. In nutshell, majority of the cardiac patients [69 (62.5%)] were considered as having good sleep status with the value of PSQI score less than five, while the remaining 42 (37.8%) were considered as poor sleepers with PSQI score five, or more than five (online supplementary file in Figure 1).

Factors associated with sleep status among cardiac patients

To identify factors associated with sleep status, logistic regression analysis was applied. In the bivariate analysis, the candidate variables having p-value<0.25 were selected for the final model. Accordingly, about seven variables (sex, age, educational status, BMI, smoking, alcohol drinking and presence of comorbidity) were identified as the expected factors associated with sleep status with their specific chi-square, COR with 95%CI and p-values as explained in Table 3 in details.

Table 3.

Association of sleep status and other variables by bivariate logistic regression analysis among cardiac patients at JMC, 2019.

Dichotomous variables Categories Status of Sleep COR(95% CI) P- value X2
Good, No (%) Poor, Nº (%) Total, Nº (%)
Residence Urban 37(33.4) 22(19.8) 59(53.2) 1    
Rural 32(28.8) 22(19.8) 52(46.8) 1.05(0.4-2.2) 0.899 0.016
Sex Male 33(29.7) 27(24.4) 60(54.1) 1.96(0.8-4.3) 0.093*  
Female 36(32.4) 15(13.5) 51(45.9) 1   2.84
Age  in years ≤34 13(11.7) 4(3.6) 17(15.3) 1 0.006* 17.3
35-44 17(15.3) 17(15.3) 34(30.6) 3.2(0.28-5.2) 0.07*  
45-54 16(14.4) 6(5.4) 22(19.8) 1.2(1.6-39) 0.79  
55-64 16(14.4) 2(1.8) 18(16.2) 0.4(0.06-2.5) 0.34  
≥65 7(6.3) 13(11.7) 20(18.0) 6(1.4-25) 0.01*  
Educational status Can't read and write 10(9.0) 12(10.8) 22(19.8) 1.9(0.6-6.0) 0.26 7.8
Only  read  and write 6(5.4) 2(1.8) 8(7.2) 0.53(0.09-3.1) 0.49  
Primary school 23(20.7) 6(5.4) 29(26.1) 0.41(0.12-1.3) 0.15*  
Secondary school 14(12.6) 12(11.8) 26(23.4) 1.37(0.4-4.1) 0.57  
Higher education 16(14.4) 10(9.0) 26(23.4) 1 0.12*  
Religious status Muslim 36(32.4) 24(21.6) 60(54.1) 1.3(0.1-15) 0.81  
Orthodox 21(18.9) 11(9.9) 32(28.8) 1.048(0.08-12) 0.97  
Protestant 10(9.0) 6(5.4) 16(14.4) 1.2(0.08-16) 0.89 0.31
Catholic 2(1.8) 1(0.9) 3(2.7) 1 0.95  
Ethnicity Oromo 34(30.6) 23(20.7) 57(51.4) 1 0.85 0.78
Amhara 12(10.8) 5(4.5) 17(15.3) 0.6(0.19-1.9) 0.41  
Tigre 6(5.4) 3(2.7) 9(8.1) 0.7(0.16-3.2) 0.69  
SNNP 17(15.3) 11(9.9) 28(25.2) 0.95(0.3-2.4) 0.92  
Occupation Farmer 14(12.6) 7(6.3) 21(18.9) 1 0.82  
House wife 19(17.1) 9(8.1) 27(25.2) 0.94(0.28-3.1) 0.93  
Private 15(13.5) 14(12.6) 29(26.1) 1.86(0.58-5.9) 0.29 2.17
Public 10(9.0) 6(5.4) 16(14.4) 1.2(0.3-4.6) 0.79  
Unemployed 5(4.5) 2(1.8) 7(6.3) 0.8(0.12-5.2) 0.81  
Retired 6(5.4) 4(3.6) 10(9.0) 1.3(0.28-6.3) 0.71  
Marital status Married 40(36.1) 22(19.8) 62(55.9) 1 0.95  
Widowed 7(6.3) 5(4.5) 12(10.8) 1.29(0.3-4.5) 0.68 0.34
Divorced 12(11.8) 8(7.2) 20(18.0) 1.21(0.4-3.4) 0.71  
Single 10(9.0) 7(6.3) 17(15.3) 1.27(0.4-3.8) 0.66  
BMI Normal 45(40.5) 34(30.6) 79(71.2) 1 0.18* 3.87
Under weight 6(5.4) 1(0.9) 7(6.3) 0.22(0.002-1.9) 0.17*  
Overweight 18(16.2) 7(6.3) 25(22.5) 0.5(0.19-1.3) 0.18*  
Smoking status Smoke 5(4.5) 8(7.2) 13(11.7) 3(0.9-9.9) 0.070* 3.3
Not smoke 64(57.7) 34(30.6) 98(88.3) 1    
Alcoholic status Drinker 12(10.8) 12(10.8) 24(21.6) 1.9(0.7-4.7 0.16* 1.88
Not drinker 57(51.4) 30(27.0) 87(78.4) 1    
Chewing status Chewer 24(21.6) 17(15.3) 41(36.9) 1.2(0.57-2.8) 0.54 0.36
Not chewer 45(40.5) 25(22.6) 70(63.1) 1    
Coffee/tea drinking status Drinking 55(49.6) 33(29.7) 88(79.3) 0.9(0.3-2.3) 0.88 0.021
Not drinking 14(12.6) 9(8.1) 23(20.7) 1    
Presence of comorbidity Yes 29(26.2) 26(23.4) 55(49.5) 2.2(1.02-4.9) 0.044* 4.1
No 40(36.1) 16(14.4) 56(50.5) 1    
Duration of disease <5 years 44(39.6) 29(26.1) 73(65.8) 1.2(0.5-2.8) 0.57 0.32
>5 years 25(22.5) 13(11.7) 38(34.2) 1    
Type of disease CHD 23(20.7) 14(12.6) 37(33.3) 0.76(0.24-2.3) 0.63 3.4
RHD 4(3.6) 6(5.4) 10(9.0) 1.87(0.39-9) 0.43  
IHD 18(16.2) 8(7.2) 26(23.4) 0.55(0.15-1.9) 0.35  
HTN 14(12.6) 6(5.4) 20(18.0) 0.53(0.14-2) 0.35  
Other 10(9.0) 8(7.2) 18(16.2) 1 0.51  
NYHA classification NYHA I 17(15.3) 9(8.1) 26(23.4) 1 0.96 0.29
NYHA II 27(24.3) 17(15.3) 44(39.6) 1.18(0.4-3.2) 0.73  
NYHA III 11(9.9) 8(7.2) 19(17.1) 1.37(0.4-4.6) 0.6  

COR: Crude Odd Ratio; X2: Chi square;

*

Candidate for final mode (p-value <0.25).

Further, multivariate analysis (binary logistic regression with enter methods) was applied to identify the main predictors. Finally, two variables (age of patients more than 65 years and presence of comorbidity) were identified as the factors associated with sleep status among cardiac patients with p-value less than 0.05 and specific AOR (95% CI). Patients who had additional comorbidity were three times more likely to become poor sleepers than those who had no comorbidity and patients greater than 65 years were also about four times likely to be poor sleepers with specific AOR (95% CI) of 4.087(2.013-8.612) and 3.042(1.074-8.619) respectively as explained in Table 4 in details.

Table 4.

Association of sleep status and other variables by multivariate logistic regression analysis among cardiac patients at JMC, 2019.

Variables candidate in multivariate logistic regression AOR 95% C.I P-value
Sex (male) 2.466 0.8-7.2 0.099
Age classification (>65 years) 4.087 2.0-8.6 0.004
Education (Can't read and write) 1.113 0.2-5.9 0.900
BMI class (normal) 0.229 0.02-2.6 0.232
Smoking (yes) 3.137 0.6-16.0 0.170
Alcohol (yes) 0.739 0.18-2.9 0.671
Additional comorbidity (yes) 3.042 1.1-8.6 0.036

DISCUSSION

Among the total enrolled 111 cardiac patients, the mean age was 49±14 that ranges from 20-89 years by which majority of them 34 (30.6%) belong to interval age of 35-44 years. The present result was comparable with previous study done in the setting by Abebe et al.21 who reported the mean age of 49±16 years and comparable baseline characteristics among heart failure patients.

Majority of the cardiac disease patients 73 (65.8%) developed disease within five years with dominant NYHA stage two (39.6%) which was also supported by study of Chen et al.22, Wang et al.23 and Santos et al.14 who also reported NYHA class II dominance (72%), (63.4%) and (50.5%), respectively. The mean duration of illness was 5.1±4.87 years that range from 0.5-30 years.

The Pittsburgh Sleep Quality Index (PSQI) was used to assess the quality and patterns of sleep among cardiac patients, as it is an effective instrument used to differentiate “poor” from “good” sleep by measuring seven domains (subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication and daytime dysfunction) over the last month. The tool has internal consistency and a reliability coefficient (Cronbach’s alpha) of 0.83 for its seven components. A global sum of “5” or greater indicates a “poor” sleeper. The mean of PSQI score was 4.9±2.79 that ranges from 1-17 scores. Majority of the cardiac patients [69 (62.2%)] were considered as having good sleep status with the value of PSQI score less than five, while the rest 42 (37.8%) were considered as poor sleepers with PSQI score five or more than five. The present finding of mean PSQI score of 4.9 was within the global PSQI score range of 3-2024.

The present study revealed less magnitude of poor sleep quality (37.8%) among cardiac patient in relative to previous studies: Abebe et al.21 (81.65%), Wang et al.23 (81.2%), Moradi et al.24 (79%), Chen et al.22 (74.4%) and Santos et al.14 (68.5) who reported high magnitude of poor sleep quality among heart patients probably due to age differences [all reported mean age greater than the present mean age (48.9, 74.0, 73.1, 67.8 and 57.8, respectively)], socio-demographic differences and variation in season of data collection period. But, the prevalence of poor sleep quality in present finding was in harmony with the study of Wong and Fielding25 who reported the prevalence of poor sleep quality/insomnia of (39.4%) among total population.

The mean of PSQI score of 4.37±2.64 in the present study was not comparable with findings of Abebe et al.21, Santos et al.14, Moradi et al.24 and Wang et al.23 who reported higher mean of PSQI score of 9.23, 10.8, 9.8 and 10.0, respectively; probably due to study population differences especially age difference (the present participant were relatively less elders/low mean age) as studies confirmed disturbance of sleep quality as age advances26,27. The study also revealed that status of sleep quality affected by different age groups. The prevalence of insomnia was 44.4% for the elderly group and 31.4% for the younger group as compared and reported by Gau et al.28.

In general, the prevalence of sleep disturbances among heart failure patients was within the range of 35-70% and the present finding revealed the rate of poor sleep quality (37.8%) that also supported by other studies who reported the rate of poor sleep quality within these ranges17,29,30.

The mean of duration of time spent on the bed by cardiac patients was 8.7±1.5 hours that range from 2-14 hours while mean duration of actual sleep time was 7.9±2.4 hours that range from 2-12 hours. This finding was relatively higher than mean daily duration of sleep of 5.6 hours and 6 hours reported by Moradi et al.24 and Santos et al.14, respectively, probably due to socio-demographic difference.

The mean of duration of time taken to fall asleep was 29.72±19.3 minutes that range from 5-90 minutes, which was in line with the study of Santos et al.14 and Zeighami and Shahparian31 who reported the mean duration of sleep latency of 42±36 minutes and 42 minutes, respectively.

Cardiac patients were subjectively allocated their sleep status as very good 65 (58.6%), fairly good 31 (27.9%), fairly bad 10 (9.0%) and very bad 5 (4.5%) for component I of PSQI tool. But, this pattern of allocation by component I where patients with score 0 (very good) dominant was not in line with studies of Abebe et al.21, Santos et al.14 and Wang et al.23, who reported allocation of more patients in score 2 (53%, 47% and 31%), respectively.

When cardiac patients were assessed for sleep status by component II of PSQI tool, they were belong to fairly good 64 (57.7%) who fall asleep within 16-30 minutes, fairly bad 32 (28.8%) who fall asleep within 31-60 minutes, very good 9 (8.1%) who fall asleep within 15 minutes and very bad 6 (5.4%) who fall asleep after 60 minutes where this pattern was also supported by study of Abebe et al.21 who reported majority of patients (35.3%) with score 1 by component II of PSQI tool.

According to assessment done by PSQI tool component III, majority of cardiac patients [75 (67.6%) were belong to score 0 (very good) having more than 7 hours of actual sleeping per night followed by score 2/fairly bad 18 (16.2%), score 1/fairly good 14 (12.6%) and score 2/fairly bad 4 (3.6%). This pattern was also supported by study of Abebe et al.21 who reported allocation of majority of patients (43.5%) with score 0 by component III PSQI tool.

According to assessment done by PSQI tool component IV, the scores of habitual sleep efficiency of cardiac patients were allocated to score 0 (very good) 74 (66.7%), score 1/fairly good 22 (19.8%), score 2/fairly bad 9 (8.1%) and score 3/very bad 6 (5.4%) where this pattern was also supported by study of Abebe et al.21 who reported majority of patients (29.5%) with score 0 using component IV PSQI tool.

When cardiac patients were assessed with component V of PSQI tool (sleep disturbances), they were only classified to score 1/fairly good 82 (73.9%) and score 2/fairly bad 29 (26.2%) while there was no any patients with score 0 and 3. However, this pattern was not supported by study of Abebe et al.21 who also reported the prevalence of 2.9% and 4.3 % in score 0 and 3, respectively, by component V PSQI tool.

According to assessment performed by PSQI tool component VI (use of sleep medicine), majority of cardiac patients 100 (90.1%) were not used medication to induce sleep within the past one month while the rest use medication to induce sleep within the past one month at frequency of less than once a week 8 (7.2%), once to twice a week 3 (2.7%). This pattern was also in harmony with the studies of Santos et al.14 and Abebe et al.21 who revealed that 89.5% and 95.7% of the study participants didn’t use medication to sleep respectively. But, this finding was against the study of Moradi et al.24 who reported that only about 61.5% of participants didn’t use medication to induce sleep.

According to assessment by PSQI tool component VII (daytime dysfunction), the scores of daytime dysfunction of cardiac patients were belong to score 0 (very good) 60 (54.1%), score 1/fairly good 41 (36.9%), score 2/fairly bad 10 (9.0%) and no patients with score 3/very bad. This pattern was against the study of Abebe et al.21 who reported that 20.9% of participants allocated to score 3 probably due to study population differences especially age difference (the present participant were relatively less elders/low mean age).

In nutshell, when all components of PSQI were evaluated for screening sleep quality, worst scale of poor sleep (score 3) was only discerned by component I-IV with the prevalence of 4.5%, 5.4%, 3.6% and 5.4%, respectively. But, the prevalence of score 3 was 0% if assessed by other PSQI components of V-VII.

In bivariate analysis of logistic regression, the correlation of poor sleep status was observed with about seven variables (sex (male) 1.96 (0.8-4.3), age (>65 years) 6 (1.4-25), educational status (illiterate) 1.9 (0.6-6.0), BMI (overweight) 0.5 (0.19-1.3), smoking (yes) 3 (0.9-9.9), alcohol drinking (yes) 1.9 (0.7-4.7 and presence of comorbidity (yes) 2.2 (1.02-4.9)) having p-value less than 0.25 and specific COR with 95%CI as explained in Table 3 in detail. However, only two variables (age of patients more than 65 years and presence of comorbidity) were identified as associated factors with poor sleep quality having p-value less than 0.05 and specific AOR with 95%CI of 4.087 (2.013-8.612) and 3.042 (1.074-8.619), respectively, as detailed in Table 4 from the results of multivariate analysis of logistic regression.

The possible interpretation and inference was drawn as; patients who had additional comorbidity were three times more likely to become poor sleepers than those who had no comorbidity and patients greater than 65 years were also about four times likely to be poor sleepers. This finding was also supported by other studies23,24,28,31,32 where different predictors (comorbidity, age, educational status, smoking, income and BMI) were determined to affect sleep quality.

CONCLUSION

Despite, the present finding revealed less prevalence (37.8%) of poor sleep quality in relative to studies conducted so far among heart failure patients for possible reasons, it is common in heart failure patients, especially among aged patients of >65 years and with comorbidities.

ACKNOWLEDGEMENTS

Authors kindly acknowledge Jimma University, data collectors and the participants of the study.

SUPPLEMENT FILES.

Figure 1.

Figure 1

Status of sleep among cardiac patients at JMC, 2019

Footnotes

FUNDING

The authors did this study by their own cost.

AUTHORS’ CONTRIBUTIONS

YG - involved in research concept and design, collection and/or assembly of data, data analysis and interpretation, writing the article, critical revision of the article, final approval of article and statistical analysis. WR - involved in research data analysis and interpretation, writing the manuscript, critical revision of the article, final approval of article and statistical analysis. HA - involved in research concept and design, critical revision of the article, final approval of article.

COMPETING INTERESTS

The authors declare that they have no competing interests.

REFERENCES

  • 1.Wintrobe MM, Thorn GW, Adams R, Braunwald E, Isselbacher KJ, Petersdorf RG. Harrison's principles of internal medicine. New York: McGraw-Hill; 1974. [Google Scholar]
  • 2.Roger VL. Epidemiology of heart failure. Circ Res. 2013 Aug;113(6):646–659. doi: 10.1161/CIRCRESAHA.113.300268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Libby P, Bonow RO, Mann DL, Zipes DP. Braunwald's heart disease: a textbook of cardiovascular medicine. Amsterdam: Elsevier Health Sciences; 2007. [Google Scholar]
  • 4.Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011 Jan;8(1):30–41. doi: 10.1038/nrcardio.2010.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Dijk DJ, Cajochen C. Melatonin and the circadian regulation of sleep initiation, consolidation, structure, and the sleep EEG. J Biol Rhythms. 1997 Dec;12(6):627–635. doi: 10.1177/074873049701200618. [DOI] [PubMed] [Google Scholar]
  • 6.Dijk DJ, Czeisler CA. Contribution of the circadian pacemaker and the sleep homeostat to sleep propensity, sleep structure, electroencephalographic slow waves, and sleep spindle activity in humans. Pt 1J Neurosci. 1995 May;15(5):3526–3538. doi: 10.1523/JNEUROSCI.15-05-03526.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kecklund G, Axelsson J. Health consequences of shift work and insufficient sleep. BMJ. 2016 Nov;355:i5210–i5210. doi: 10.1136/bmj.i5210. [DOI] [PubMed] [Google Scholar]
  • 8.Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193–213. doi: 10.1016/0165-1781(89)90047-4. [DOI] [PubMed] [Google Scholar]
  • 9.Carpenter JS, Andrykowski MA. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res. 1998 Jul;45(1):5–13. doi: 10.1016/s0022-3999(97)00298-5. [DOI] [PubMed] [Google Scholar]
  • 10.Foley D, Ancoli-Israel S, Britz P, Walsh J. Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation Sleep in America Survey. J Psychosom Res. 2004 May;56(5):497–502. doi: 10.1016/j.jpsychores.2004.02.010. [DOI] [PubMed] [Google Scholar]
  • 11.Parker KP, Dunbar SB. Sleep and heart failure. J Cardiovasc Nurs. 2002;17(1):30–41. doi: 10.1097/00005082-200210000-00004. [DOI] [PubMed] [Google Scholar]
  • 12.Erickson VS, Westlake CA, Dracup KA, Woo MA, Hage A. Sleep disturbance symptoms in patients with heart failure. AACN Adv Crit Care. 2003;14(4):477–487. doi: 10.1097/00044067-200311000-00009. [DOI] [PubMed] [Google Scholar]
  • 13.Dos MS, Barbosa RL. Factors associated to sleep pattern in heart failure patients. Rev Esc Enferm USP. 2011 Oct;45(5):1105–1112. doi: 10.1590/s0080-62342011000500011. [DOI] [PubMed] [Google Scholar]
  • 14.Santos MA, Guedes ES, Barbosa RL, Cruz DA. Sleeping difficulties reported by patients with heart failure. Rev Lat Am Enfermagem. 2012 Jul-Aug;20(4):644–650. doi: 10.1590/s0104-11692012000400003. [DOI] [PubMed] [Google Scholar]
  • 15.Chen HM, Clark AP. Sleep disturbances in people living with heart failure. J Cardiovasc Nurs. 2007 May-Jun;22(3):177–185. doi: 10.1097/01.JCN.0000267823.19826.ca. [DOI] [PubMed] [Google Scholar]
  • 16.Lanfranchi PA, Somers VK. Sleep-disordered breathing in heart failure: characteristics and implications. Respir Physiol Neurobiol. 2003 Jul;136(2-3):153–165. doi: 10.1016/s1569-9048(03)00078-8. [DOI] [PubMed] [Google Scholar]
  • 17.Redeker NS. Sleep-disordered breathing in patients with heart failure: an update. Yale University School of Nursing; 2005:15–24. [Google Scholar]
  • 18.Birhanu TE, Getachew B, Gerbi A, Dereje D. Prevalence of poor sleep quality and its associated factors among hypertensive patients on follow up at Jimma University Medical Center. J Hum Hypertens. 2020 Mar 03; doi: 10.1038/s41371-020-0320-x. [Epub ahead of print] [DOI] [PubMed] [Google Scholar]
  • 19.Smyth C. The Pittsburgh sleep quality index (PSQI) J Gerontol Nurs. 1999 Dec;25(12):10–11. doi: 10.3928/0098-9134-19991201-10. [DOI] [PubMed] [Google Scholar]
  • 20.Salahuddin M, Maru TT, Kumalo A, Pandi-Perumal SR, Bahammam AS, Manzar MD. Validation of the Pittsburgh Sleep Quality Index in community dwelling Ethiopian adults. Health Qual Life Outcomes. 2017 Mar;15(1):58–58. doi: 10.1186/s12955-017-0637-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Abebe A, Temamen T, Fikadu B, Gugsa N. Perceived sleep quality of heart failure patients at Jimma university specialized hospital (JUSH) chronic follow up clinic south west Ethiopia, 2015. J Health Med Nurs. 2015 Oct;20:34–44. [Google Scholar]
  • 22.Chen HM, Clark AP, Tsai LM, Chao YFC. Self-reported sleep disturbance of patients with heart failure in Taiwan. Nurs Res. 2009 Jan-Feb;58(1):63–71. doi: 10.1097/NNR.0b013e31818c3ea0. [DOI] [PubMed] [Google Scholar]
  • 23.Wang TJ, Lee SC, Tsay SL, Tung HH. Factors influencing heart failure patients' sleep quality. J Adv Nurs. 2010 Aug;66(8):1730–1740. doi: 10.1111/j.1365-2648.2010.05342.x. [DOI] [PubMed] [Google Scholar]
  • 24.Moradi M, Mehrdad N, Nikpour S, Haghani H, Aalaa M, Sanjari M, et al. Sleep quality and associated factors among patients with chronic heart failure in Iran. Med J Islam Repub Iran. 2014 Dec;28:149–149. [PMC free article] [PubMed] [Google Scholar]
  • 25.Wong WS, Fielding R. Prevalence of insomnia among Chinese adults in Hong Kong: a population-based study. Pt 1J Sleep Res. 2011 Mar;20(1):117–126. doi: 10.1111/j.1365-2869.2010.00822.x. [DOI] [PubMed] [Google Scholar]
  • 26.Ohayon MM, Sagales T. Prevalence of insomnia and sleep characteristics in the general population of Spain. Sleep Med. 2010 Dec;11(10):1010–1018. doi: 10.1016/j.sleep.2010.02.018. [DOI] [PubMed] [Google Scholar]
  • 27.Bittencourt LRA, Santos-Silva R, Taddei JA, Andersen ML, Mello MT, Tufik S. Sleep complaints in the adult Brazilian population: a national survey based on screening questions. J Clin Sleep Med. 2009 Oct;5(5):459–463. [PMC free article] [PubMed] [Google Scholar]
  • 28.Gau FY, Chen XP, Wu HY, Lin M, Chao YFC. Sleep-related predictors of quality of life in the elderly versus younger heart failure patients: a questionnaire survey. Int J Nurs Stud. 2011;48(4):419–428. doi: 10.1016/j.ijnurstu.2010.07.011. [DOI] [PubMed] [Google Scholar]
  • 29.Broström A, Strömberg A, Dahlström U, Fridlund B. Sleep difficulties, daytime sleepiness, and health-related quality of life in patients with chronic heart failure. J Cardiovasc Nurs. 2004 Jul-Aug;19(4):234–242. doi: 10.1097/00005082-200407000-00003. [DOI] [PubMed] [Google Scholar]
  • 30.Redeker NS, Stein S. Characteristics of sleep in patients with stable heart failure versus a comparison group. Heart Lung. 2006 Jul-Aug;35(4):252–261. doi: 10.1016/j.hrtlng.2005.10.007. [DOI] [PubMed] [Google Scholar]
  • 31.Zeighami MS, Shahparian M. Evaluation of sleep problems and its associated factors in male patients with systolic heart failure. QOM Univ Med Sci J. 2013;6(4):64–73. [Google Scholar]
  • 32.Skobel E, Norra C, Sinha A, Breuer C, Hanrath P, Stellbrink C. Impact of sleep-related breathing disorders on health-related quality of life in patients with chronic heart failure. Eur J Heart Fail. 2005;7(4):505–511. doi: 10.1016/j.ejheart.2004.07.020. [DOI] [PubMed] [Google Scholar]

Articles from Sleep Science are provided here courtesy of Brazilian Association of Sleep and Latin American Federation of Sleep

RESOURCES